About Centrient Pharmaceuticals
Centrient Pharmaceuticals is a company based in Rotterdam (Netherlands) founded in 1869. The company has 613 employees as of March 23, 2024. Centrient Pharmaceuticals has completed 1 acquisition, including Astral SteriTech.
- Headquarter Rotterdam, Netherlands
- Employees 613 as on 23 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Centrient Pharmaceuticals India Private Limited
- Date of Incorporation 19 Jan, 1993
- Jurisdiction Toansa, Punjab, India
-
Annual Revenue
$223 M (USD)13.46as on Mar 31, 2023
-
Net Profit
$6.4 M (USD)-31.41as on Mar 31, 2023
-
EBITDA
$16.05 M (USD)-9.72as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
613
as on Mar 23, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Centrient Pharmaceuticals
Unlock access to complete
Software Development Team
40 people
Finance and Accounting
15 people
Human Resources and Administration
13 people
Leadership Team
10 people
Sales and Marketing
7 people
Product Management Team
4 people
Global Team
3 people
Senior Team
3 people
Unlock access to complete
Funding Insights of Centrient Pharmaceuticals
Detailed funding history for Centrient Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Centrient Pharmaceuticals
Centrient Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Astral SteriTech.
Investment portfolio details for Centrient Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Regulatory and quality management services are provided to biopharma firms.
|
Locked | Locked | 1991 | Locked |
Complete acquisition details for Centrient Pharmaceuticals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Centrient Pharmaceuticals
Detailed financials for Centrient Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Centrient Pharmaceuticals Comparisons
Peer comparison for Centrient Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Centrient Pharmaceuticals
Detailed competitors of Centrient Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Centrient Pharmaceuticals
Complete news archive for Centrient Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Centrient Pharmaceuticals
Centrient Pharmaceuticals was founded in 1869.
Centrient Pharmaceuticals is headquartered in Rotterdam, Netherlands. It is registered at Rotterdam, South Holland, Netherlands.
As of Mar 23, 2024, the latest employee count at Centrient Pharmaceuticals is 613.
Annual revenue of Centrient Pharmaceuticals is $223M as on Mar 31, 2023.
Centrient Pharmaceuticals was founded in 1869 and is headquartered in Rotterdam, Netherlands. Operations focus on the pharmaceutical sector, where active pharmaceutical ingredients and finished dosage forms, such as tablets, syrups, and suspensions, are produced. Products encompass antibiotics like beta-lactams including clavulanic acid and amoxicillin, antifungals, and statins. Manufacturing facilities are certified by the FDA.
Centrient Pharmaceuticals has made 1 acquisition, including Astral SteriTech.